Mr. Damien McCallion:

With what has happened in the past week, we are not in a position to answer that directly. There is a question of supply and I mentioned those changes. We had further changes from AstraZeneca in its profiling. There will be an immediate effect from that in the next couple of weeks. We are not in a position to say that is there.